In This Article:
- By insider
President and CEO of Exact Sciences Corp (EXAS) Kevin T Conroy sold 163,514 shares of EXAS on 11/12/2018 at an average price of $69 a share. The total sale was $11.3 million.
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer. Exact Sciences Corp has a market cap of $8.41 billion; its shares were traded at around $68.45 with and P/S ratio of 20.89.
-
Warning! GuruFocus has detected 2 Warning Sign with EXAS. Click here to check it out.
-
The intrinsic value of EXAS
CEO Recent Trades:
-
President and CEO Kevin T Conroy sold 163,514 shares of EXAS stock on 11/12/2018 at the average price of $69. The price of the stock has decreased by 0.8% since.
Directors and Officers Recent Trades:
-
Director Katherine S Zanotti sold 7,667 shares of EXAS stock on 11/12/2018 at the average price of $69. The price of the stock has decreased by 0.8% since.
-
Chief Science Officer Graham Peter Lidgard sold 38,311 shares of EXAS stock on 11/07/2018 at the average price of $75.01. The price of the stock has decreased by 8.75% since.
-
Chief Science Officer Graham Peter Lidgard sold 79,673 shares of EXAS stock on 11/01/2018 at the average price of $71.73. The price of the stock has decreased by 4.57% since.
For the complete insider trading history of EXAS, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 2 Warning Sign with EXAS. Click here to check it out.
-
The intrinsic value of EXAS